Tang Capital Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Tang Capital Management’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25,516	Closed	-$487K	–	215
2025 Q1	$487K	Buy	25,516 +17,016	+200%	+$535K	0.03%	184
2024 Q4	$308K	Buy	+8,500	New	+$237K	0.02%	178
2023 Q2	–	Sell	-2,660	Closed	-$223K	–	109
2023 Q1	$223K	Buy	2,660 +1,454	+121%	+$127K	0.03%	96
2022 Q4	$103K	Buy	+1,206	New	+$92K	0.01%	86
2022 Q3	–	Sell	-60,000	Closed	-$1.32M	–	98
2022 Q2	$1.32M	Hold	60,000	–	–	0.2%	57
2022 Q1	$2.95M	Hold	60,000	–	–	0.59%	38
2021 Q4	$3.47M	Hold	60,000	–	–	0.7%	24
2021 Q3	$4.88M	Hold	60,000	–	–	1.01%	16
2021 Q2	$5.83M	Buy	+60,000	New	+$6.05M	1.16%	11

Other funds holding RVPH

Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

PAP

Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Tang Capital Management's RVPH Position: Q2 2025 in Review

Tang Capital Management sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2025, closing a stake of 25,516 shares — an estimated $487K sold.

Tang Capital Management first reported a position in RVPH in Q2 2021 and held it in 9 quarters. The position peaked at $5.83M in Q2 2021. 46 funds tracked by Wall St. Rank hold RVPH as of Q2 2025.

Tang Capital Management reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2025 after selling out during the quarter.
Tang Capital Management sold 25,516 REVIVA PHARMA HLDGS INC shares in Q2 2025, an estimated $487K.
Tang Capital Management first reported a position in REVIVA PHARMA HLDGS INC in Q2 2021 and held it in 9 quarters.
Tang Capital Management's REVIVA PHARMA HLDGS INC position peaked at $5.83M in Q2 2021.
46 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2025.

Based on Tang Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.